🔗 Share this article

An underground economy for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Investigational Drug Acquiring Popularity Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are urged to contact these accounts directly for source information, while also obtaining promotional offers.

Active Trade on Social Networks

Separately, a robust market exists on Telegram, where communities with thousands of participants share “before and after” images, administration instructions and claims of rapid British shipping. Vendors market the drug there before directing buyers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could assist patients lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Experts Voice Worries

Nevertheless, physicians and chemists have warned that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could result in individuals administering products of uncertain source.

Some experts stated the popularity for retatrutide could be linked to the increasing cost of licensed weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the British medical regulations.

Several influencers try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still violate pharmaceutical, advertising, and consumer laws, potentially leading to penalties, prosecution or imprisonment.

Service Response and Material Removal

Based on TikTok, the platform has removed problematic content and banned associated keywords and query recommendations. The company stated it was committed to maintaining the platform safe and allocating resources in strengthening compliance measures.

Digital Marketplace Activities

Investigations also found groups with up to 9,000 participants selling the experimental drug using Telegram's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately brings up channels with thousands of users, filled with images of weight loss, positive reviews and step-by-step guides for mixing or administering at home.

After moments of joining one group, a seller shared WhatsApp details, where the majority of transactions occur. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one inquired about weight, health issues or previous experience.

Product Information and Pricing

Inside these communities, posts show black plastic parcels with postal service labels, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at home with purified liquid, or ready-to-use injectors usually sold at 160 pounds for 20 milligrams. When asked how much time a pen should last, sellers give contradictory responses ranging from a several days to “depends on your body”.

Service Oversight and Safety Actions

A representative for Telegram said it regularly monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are injecting substances they cannot confirm. Even if the science behind retatrutide is sound, these digital versions may not contain what they advertise,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With costs increasing, patients are using online platforms. But counterfeit injections are highly risky. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she said.

Her team has already seen individuals harmed by personal administration from unverified suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A representative from Eli Lilly stated retatrutide was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company investigational product not yet authorized … may expose users to potentially serious medical dangers”.